Reversible antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inosi...

Basic Information

ID: ALA3387263

Type: Functional

Description: Reversible antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production at 1 uM incubated for 15 to 60 mins before I-BOP addition and measured after 4 consecutive drug washout by HTRF assay

Format: BAO_0000219

Organism: Homo sapiens

Cell type: HEK293-A

Target:  Thromboxane A2 receptor(ALA2069)

Document:  ALA3351871

Reversible antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production at 1 uM incubated for 15 to 60 mins before I-BOP addition and measured after 4 consecutive drug washout by HTRF assay: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
367.852.882.88
379.872.802.80
346.475.285.28
488.055.385.38
445.974.144.14